BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kong W, Wang X, Zuo X, Mao Z, Cheng Y, Chen W. Development and Validation of an Immune-Related lncRNA Signature for Predicting the Prognosis of Hepatocellular Carcinoma. Front Genet 2020;11:1037. [PMID: 33101369 DOI: 10.3389/fgene.2020.01037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Jiang L, Li H, Zhao D, Li W. A Prognostic Model for Patients with Hepatocellular Carcinoma Based on Hypoxia-Related Long Noncoding RNAs. Journal of Nanomaterials 2022;2022:1-10. [DOI: 10.1155/2022/4642477] [Reference Citation Analysis]
2 Pan X, Bi F. A Potential Immune-Related Long Non-coding RNA Prognostic Signature for Ovarian Cancer. Front Genet 2021;12:694009. [PMID: 34367253 DOI: 10.3389/fgene.2021.694009] [Reference Citation Analysis]
3 Wang L, Ge X, Zhang Z, Ye Y, Zhou Z, Li M, Yan H, Wu L, Bai Q, Li J, Zhu J, Wang Y. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma. Front Genet 2021;12:682082. [PMID: 34745200 DOI: 10.3389/fgene.2021.682082] [Reference Citation Analysis]
4 Chen B, Yang Z, Lang Z, Tao Q, Zhang R, Zhan Y, Xu X, Zhu K, Zheng J, Yu Z, Yu S. M6A-related lncRNAs predict clinical outcome and regulate the tumor immune microenvironment in hepatocellular carcinoma. BMC Cancer 2022;22:867. [PMID: 35941582 DOI: 10.1186/s12885-022-09925-2] [Reference Citation Analysis]
5 Zhang Z, Wang F, Zhang J, Zhan W, Zhang G, Li C, Zhang T, Yuan Q, Chen J, Guo M, Xu H, Yu F, Wang H, Wang X, Kong W. An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma. Front Pharmacol 2022;13:854851. [PMID: 35431958 DOI: 10.3389/fphar.2022.854851] [Reference Citation Analysis]
6 Jin C, Li R, Deng T, Li J, Yang Y, Li H, Chen K, Xiong H, Chen G, Wang Y. Identification and Validation of a Prognostic Prediction Model of m6A Regulator-Related LncRNAs in Hepatocellular Carcinoma. Front Mol Biosci 2021;8:784553. [PMID: 34988119 DOI: 10.3389/fmolb.2021.784553] [Reference Citation Analysis]
7 Wu ZH, Li ZW, Yang DL, Liu J. Development and Validation of a Pyroptosis-Related Long Non-coding RNA Signature for Hepatocellular Carcinoma. Front Cell Dev Biol 2021;9:713925. [PMID: 34869306 DOI: 10.3389/fcell.2021.713925] [Reference Citation Analysis]
8 Zou W, Wang Z, Wang F, Li L, Liu R, Hu M. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma. BMC Cancer 2021;21:608. [PMID: 34034689 DOI: 10.1186/s12885-021-08322-5] [Reference Citation Analysis]
9 Wu J, Ren X, Wang N, Zhou R, Chen M, Cai Y, Lin S, Zhang H, Xie X, Dang C, Zhang S, Zhou Z. A Mutation-Related Long Noncoding RNA Signature of Genome Instability Predicts Immune Infiltration and Hepatocellular Carcinoma Prognosis. Front Genet 2021;12:779554. [PMID: 34880908 DOI: 10.3389/fgene.2021.779554] [Reference Citation Analysis]
10 Yang D, Ma J, Ma XX. CDKN2B-AS1 Promotes Malignancy as a Novel Prognosis-Related Molecular Marker in the Endometrial Cancer Immune Microenvironment. Front Cell Dev Biol 2021;9:721676. [PMID: 34712660 DOI: 10.3389/fcell.2021.721676] [Reference Citation Analysis]
11 Zhang L, Tang X, Wan J, Zhang X, Zheng T, Lin Z, Liu T. Construction of a Novel Signature and Prediction of the Immune Landscape in Soft Tissue Sarcomas Based on N6-Methylandenosine-Related LncRNAs. Front Mol Biosci 2021;8:715764. [PMID: 34733885 DOI: 10.3389/fmolb.2021.715764] [Reference Citation Analysis]
12 Zhang Y, Yang X, Zhou L, Gao X, Wu X, Chen X, Hou J, Wang L. Immune-related lincRNA pairs predict prognosis and therapeutic response in hepatocellular carcinoma. Sci Rep 2022;12:4259. [PMID: 35277569 DOI: 10.1038/s41598-022-08225-w] [Reference Citation Analysis]
13 Zhang Z, Zhang W, Wang Y, Wan T, Hu B, Li C, Ge X, Lu S. Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma. Front Cell Dev Biol 2022;10:792676. [PMID: 35295858 DOI: 10.3389/fcell.2022.792676] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Cai S, Hu X, Chen R, Zhang Y. Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma. Front Genet 2021;12:657051. [PMID: 34178028 DOI: 10.3389/fgene.2021.657051] [Reference Citation Analysis]
15 Chen ZA, Tian H, Yao DM, Zhang Y, Feng ZJ, Yang CJ. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma. Front Oncol 2021;11:738477. [PMID: 34568075 DOI: 10.3389/fonc.2021.738477] [Reference Citation Analysis]